Evidence map›Paper›PMID 40862258›Full record

ArticleSAGE open medicine2025

Pharmacist knowledge, attitude, and practice regarding nicotine replacement therapy usage in Iraq.

Khansaa A Ibrahim Albaroodi

Abstract read
In one paragraph

Article in SAGE open medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Khansaa A Ibrahim AlbaroodiPharmacy Department, Al-Zahrawi University College, Karbala, Iraq.ORCID https://orcid.org/0000-0003-4523-150X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The tobacco epidemic represents one of the most significant public health challenges faced globally. Nicotine replacement therapy was developed to substitute for the nicotine contained in tobacco products temporarily. The objective of this study was to investigate pharmacists' knowledge, attitudes, and practices regarding the utilization of nicotine replacement therapy in Iraq. Methods: This cross-sectional study involved 300 pharmacists across five provinces from October 1, 2023 to December 31, 2023. Results: Indicate that 300 pharmacists participated in the analysis, with approximately two-thirds identifying as male. About two-thirds of the participants (95% confidence interval: 65.3%) expressed that they knew how to use nicotine replacement therapy. Furthermore, about half of them (95% confidence interval: 50.3%) reported their awareness of how to make dose titration, with a majority agreeing that the assessment of nicotine dependence influences the selection of nicotine replacement therapy products. Fair knowledge was associated with each degree of education, not attending training programs, and the availability of nicotine replacement therapy in their pharmacies (0.01, 0.002, 0.003, respectively). Conclusions: There exists a critical necessity for pharmacists to augment their comprehension of the medications utilized in smoking cessation. Such enhancement is essential to improve their practices and, consequently, to attain superior outcomes in supporting individuals in their efforts to quit smoking.

Indexed as

attitudeknowledgenicotine replacement therapypharmacistpractice

Identifiers

PMID40862258
PMCPMC12375149

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.